- 全部删除
您的购物车当前为空
Folic acid 是一种口服活性必需营养素,参与DNA/RNA合成及新细胞的产生与维持,具有抗抑郁样作用,能降低新生儿神经管缺陷风险,缺乏时可引起巨幼红细胞性贫血、大红细胞性贫血、神经管闭合缺陷、肿瘤及衰老等疾病,且常用于因叶酸缺乏相关疾病研究及诱导急性肾损伤模型。

Folic acid 是一种口服活性必需营养素,参与DNA/RNA合成及新细胞的产生与维持,具有抗抑郁样作用,能降低新生儿神经管缺陷风险,缺乏时可引起巨幼红细胞性贫血、大红细胞性贫血、神经管闭合缺陷、肿瘤及衰老等疾病,且常用于因叶酸缺乏相关疾病研究及诱导急性肾损伤模型。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 50 mg | ¥ 131 | In stock | |
| 100 mg | ¥ 176 | In stock | |
| 500 mg | ¥ 377 | In stock | |
| 1 g | ¥ 543 | In stock | |
| 2 g | ¥ 791 | In stock | |
| 5 g | ¥ 1,320 | In stock | |
| 10 g | ¥ 1,880 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 415 | In stock |
Folic acid 相关产品
| 产品描述 | Folic acid is an orally active essential nutrient involved in the synthesis of DNA/RNA and the production and maintenance of new cells. It exhibits antidepressant-like effects and can reduce the risk of neural tube defects in newborns. Folate deficiency can cause megaloblastic anemia, macrocytic anemia, neural tube closure defects, tumors, and aging-related diseases. Folic acid is also commonly used in research on folate deficiency-related conditions and to induce acute kidney injury models. |
| 靶点活性 | FRα:0.0015 µg/mL, FRβ:0.0015 µg/mL |
| 体外活性 | 方法: HUVEC 细胞用 Folic acid (2.5-100 µM) 处理 48 h,使用 xCELLigence RTCA real-time cell analyzer 检测细胞增殖。 |
| 体内活性 | 方法: 为研究在抑郁症行为模型中的作用,将 Folic acid (1-100 mg/kg) 单次灌胃给药给 Swiss 小鼠,进行强迫游泳试验 (FST) 和尾部悬吊试验 (TST)。 |
| 细胞实验 | To determine the effect of FA supplementation on BRCA1 and BRCA2 mRNA expression, all cell lines were treated with 0, 25, 50, 75, or 100 nmol/L FA for 72 hours before harvesting in TRI Reagent according to the manufacturer’s instructions. (Only for Reference) |
| 别名 | 叶酸, Vitamin M, Vitamin B9, Pteroylglutamic acid, Folate, Folacin |
| 分子量 | 441.40 |
| 分子式 | C19H19N7O6 |
| CAS No. | 59-30-3 |
| Smiles | NC1=NC(O)=C2N=C(CNC3=CC=C(C=C3)C(=O)NC(CCC(O)=O)C(O)=O)C=NC2=N1 |
| 密度 | 1.68 g/cm3 |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 25.00 mg/mL (56.64 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2.50 mg/mL (5.66 mM), Suspension. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容